Home Pozen buying Canada's Tribute Pharmaceuticals for US$146 million
 

Keywords :   


Pozen buying Canada's Tribute Pharmaceuticals for US$146 million

2015-06-08 22:49:01| Biotech - Topix.net

U.S. specialty drug company Pozen Inc. announced Monday that it plans to acquire Tribute Pharmaceuticals Canada in a deal valued at about US$146 million. After the acquisition, expected to be competed in the fourth quarter, the combined company will change its name to Aralez Pharmaceuticals PLC and move its headquarters to Ireland to benefit from lower corporate tax rates in that country.

Tags: million buying tribute pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
04.07Atlantic Tropical Weather Outlook
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Public Advisory Number 24A
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Eastern North Pacific Tropical Weather Outlook
04.07 Mankiewicz Supplies Eye-catching Coatings for the CLAAS Anniversary Combine Harvester
04.07AR/VR panel shipments to increase 12% in 2024
04.07Astro Malaysia presents results for quarter ended 30 April 2024
More »